# Betty Diamond

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/betty-diamond/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,302 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 85 |
| i10-index | 310 |
| Last Known Institution | Feinstein Institute for Medical Research |
| OpenAlex ID | https://openalex.org/A5089808423 |
| ORCID iD | https://orcid.org/0000-0002-3250-3804 |
| Works | 611 |

## Researcher papers

- [2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology/)
- [2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology-2/)
- [Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus](https://scholariq.org/papers/combined-oral-contraceptives-in-women-with-systemic-lupus-erythematosus/)
- [Autoimmune Diseases](https://scholariq.org/papers/autoimmune-diseases/)
- [The immune cell landscape in kidneys of patients with lupus nephritis](https://scholariq.org/papers/the-immune-cell-landscape-in-kidneys-of-patients-with-lupus-nephritis/)
- [Effect of long‐term belimumab treatment on b cells in systemic lupus erythematosus: Extension of a phase II, double‐blind, placebo‐controlled, dose‐ranging study](https://scholariq.org/papers/effect-of-long-term-belimumab-treatment-on-b-cells-in-systemic-lupus/)
- [Losing your nerves? Maybe it's the antibodies](https://scholariq.org/papers/losing-your-nerves-maybe-it-s-the-antibodies/)
- [Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis](https://scholariq.org/papers/phase-ii-randomized-trial-of-rituximab-plus-cyclophosphamide-followed-by/)
- [Amyloid-β <sup>11</sup> C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials](https://scholariq.org/papers/amyloid-sup-11-sup-c-pib-pet-imaging-results-from-2-randomized-bapineuzumab/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [Feinstein Institute for Medical Research](https://scholariq.org/institutions/feinstein-institute-for-medical-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.